Bengaluru, India

Shruti Srivastava

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Zumutor Biologics Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shruti Srivastava. Retrieved from https://idiyas.com/inventor/shruti-srivastava-m9cbkc8i

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 20.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Shruti Srivastava in Cancer Therapeutics

Introduction

Shruti Srivastava is an accomplished inventor based in Bengaluru, India. She has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutics for cancer treatment. Her work focuses on innovative solutions that address critical health challenges.

Latest Patents

Shruti holds a patent for "Antibodies that bind to C-type lectin domain family 2 member D (CLEC2D)." This patent relates to novel anti-CLEC2D antibodies and their compositions and methods of use. These antibodies are utilized as therapeutics and have applications in prognostic and diagnostic settings for various cancers and other diseases. She has 1 patent to her name.

Career Highlights

Shruti is currently employed at Zumutor Biologics Inc., where she continues to advance her research and development efforts. Her work at the company emphasizes the importance of innovative approaches in the fight against cancer.

Collaborations

Some of her notable coworkers include Kavitha Iyer Rodrigues and Maloy Ghosh, who contribute to the collaborative environment at Zumutor Biologics Inc. Their combined expertise enhances the potential for groundbreaking discoveries in the field.

Conclusion

Shruti Srivastava's innovative work in developing anti-CLEC2D antibodies showcases her commitment to improving cancer therapeutics. Her contributions are vital in the ongoing battle against cancer and other diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…